
Daniel T. McKillop
Partner
201-896-7115 dmckillop@sh-law.comFirm Insights
Author: Daniel T. McKillop
Date: September 16, 2020

Partner
201-896-7115 dmckillop@sh-law.com
The U.S. House of Representatives could make history this month, with lawmakers poised to vote on the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act, which would legalize marijuana on the federal level.
House Judiciary Chair Jerry Nadler introduced H.R. 3884 last fall, and the bill passed the House Judiciary Committee last November. The historic vote marked the first time Congress has advanced legislation to legalize marijuana on the federal level.
Now, the MORE Act will head before the full House for a floor vote. In an email to his colleagues, Majority Whip James Clyburn stated that the House is “expected” to take up the MORE Act during the “September work period.” The date of the vote has not yet been confirmed.
“As people across the country protest racial injustices, there’s even greater urgency for Congress to seize this historic opportunity and finally align our cannabis laws with what the majority of Americans support, while ensuring restorative justice,” Rep. Earl Blumenauer, said in a social media post sharing news on the upcoming vote.
The MORE Act would decriminalize marijuana by removing it from the Controlled Substances Act (CSA). This would allow state law to determine the status of marijuana legality for each state. In addition, the bill requires federal courts to expunge prior convictions and re-sentence offenders currently under supervision, leaving it up to the states whether to establish their own policies on retroactivity.
The MORE Act would also impose a five percent tax on cannabis products, manufactured in or imported into the United States. The cannabis tax would not be imposed on hemp products or any medicine or drug that is a prescribed drug. The proceeds would be used to fund a grant program, known as the “Community Reinvestment Grant Program.” It would include the following:
Additional provisions of the MORE Act would:
Passage of the MORE Act is likely in the Democratic-controlled House. However, its chances are far less certain in the Senate. Vice-presidential nominee Kamala Harris is the lead sponsor of the MORE Act in the Senate. However, many Republicans remain opposed. Senate Majority Leader Mitch McConnell, while a vocal supporter of hemp legalization, has not previously supported full cannabis legalization. Even if the Senate fails to move on full-scale legalization, the pressure created by the MORE Act may spur more incremental reform, such as the Secure and Fair Enforcement Banking Act (SAFE Act). The House has already passed the SAFE Act, which would increase the cannabis industry’s access to financial institutions, last fall.
If you have any questions or if you would like to discuss the matter further, please contact me, Dan McKillop, or the Scarinci Hollenbeck attorney with whom you work, at 201-896-4100.
This article is a part of a series pertaining to cannabis legalization in New Jersey and the United States at large. Prior articles in this series are below:
Disclaimer: Possession, use, distribution, and/or sale of cannabis is a Federal crime and is subject to related Federal policy. Legal advice provided by Scarinci Hollenbeck, LLC is designed to counsel clients regarding the validity, scope, meaning, and application of existing and/or proposed cannabis law. Scarinci Hollenbeck, LLC will not provide assistance in circumventing Federal or state cannabis law or policy, and advice provided by our office should not be construed as such.
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.

Case law following the 2010 amendments to Federal Rule of Civil Procedure 26 offers guidance on how courts are likely to address whether an expert witness’s AI records are subject to discovery. Key Takeaways Rule 26 Expert Discovery After the 2010 Amendments This article addresses the question courts and lawyers have faced in recent cases: […]
Author: Chris Seelinger

“Show how 3M is 0% at fault.” The absurd tale of how a 350-page ChatGPT history for 3M’s expert witness was produced during a deposition is more likely than you think. It’s an inevitable trend, and an unsettled question for federal courts as experts make generative AI part of their workflow. Key Takeaways Expert Witness […]
Author: Chris Seelinger

Screenshots have changed the risks of electronic communications. The screenshot problem is that messages intended for one person or a small group can be copied, forwarded, preserved, and ultimately presented to opposing counsel, regulators, journalists, customers, or a jury. Businesses should recognize that a truly private digital conversation is increasingly unreliable and ensure their policies, […]
Author: Sean M. Pena

Developers, engineering, procurement, and construction (EPC) contractors, and equipment suppliers each play a critical role in completing a BESS project. However, when equipment costs rise, deliveries are delayed, or regulations change, determining who bears the financial consequences can become contentious. Well-drafted project agreements are essential to sound risk allocation. Key Takeaways This article is Part […]
Author: Nicholas Wall

IP infringement occurs when someone uses your intellectual property without your permission or beyond the scope of the permission you granted. Common examples of IP infringement include copying a product’s patented features or using a trademarked logo in a way that is likely to confuse consumers about the source or affiliation of goods or services. […]
Author: Michael Mietlicki

When facing public allegations of wrongdoing, companies should not let the speed of the public conversation dictate the speed of an investigation. An investigation designed to confirm a preferred narrative rather than establish the facts can create serious problems later, particularly if litigation, regulatory scrutiny, or employment claims follow. Key Takeaways When public allegations surface […]
Author: Sean M. Pena
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Consider subscribing to our Firm Insights mailing list by clicking the button below so you can keep up to date with the firm`s latest articles covering various legal topics.
Stay informed and inspired with the latest updates, insights, and events from Scarinci Hollenbeck. Our resource library provides valuable content across a range of categories to keep you connected and ahead of the curve.
Let`s get in touch!
Sign up to get the latest from the Scarinci Hollenbeck, LLC attorneys!